世界复合医学2024,Vol.10Issue(4) :1-4,37.DOI:10.11966/j.issn.2095-994X.2024.10.04.01

苏子降气汤联合三子养亲汤治疗痰浊壅肺型慢性阻塞性肺疾病急性加重期的临床疗效

Clinical Efficacy of Suzi Jiangqi Decoction Combined with Sanzi Yangqin Decoction in the Treat-ment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm Turbidity Ob-structing the Lung Type

周芹 周磊
世界复合医学2024,Vol.10Issue(4) :1-4,37.DOI:10.11966/j.issn.2095-994X.2024.10.04.01

苏子降气汤联合三子养亲汤治疗痰浊壅肺型慢性阻塞性肺疾病急性加重期的临床疗效

Clinical Efficacy of Suzi Jiangqi Decoction Combined with Sanzi Yangqin Decoction in the Treat-ment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Phlegm Turbidity Ob-structing the Lung Type

周芹 1周磊2
扫码查看

作者信息

  • 1. 泰兴市中医院老年病科,江苏 泰兴 225400
  • 2. 泰兴市中医院康复科,江苏 泰兴 225400
  • 折叠

摘要

目的 探究苏子降气汤联合三子养亲汤治疗痰浊壅肺型慢性阻塞性肺疾病急性加重期患者的效果.方法 选取泰兴市中医院老年病科于2020年1月—2022年5月收治的中医辨证结果为痰浊壅肺型的80例慢性阻塞性肺疾病患者作为研究对象,患者均因疾病急性加重入院,根据随机抽签法分为两组,每组40例.对照组采用西药治疗,观察组采用苏子降气汤合三子养亲汤治疗,两组均持续治疗2周.对比两组患者的中医证候积分、肺功能指标、用药有效率及不良反应发生率.结果 用药2周后,观察组中医证候积分低于对照组,肺功能指标优于对照组,差异有统计学意义(P均<0.05);观察组用药有效率(97.50%)高于对照组(82.50%),差异有统计学意义(χ2=5.000,P=0.025);观察组不良反应发生率(5.00%)与对照组(10.00%)比较,差异无统计学意义(χ2=0.721,P=0.396).结论 采用苏子降气汤联合三子养亲汤治疗慢性阻塞性肺疾病痰浊壅肺型急性加重期,可改善患者中医证候和提高肺功能,保障用药效果及用药安全.

Abstract

Objective To explore the effect of Suzi Jiangqi decoction combined with Sanzi Yangqin decoc-tion in the treatment of patients with acute exacerbation of chronic obstructive pulmonary disease of phlegm tur-bidity obstructing lung type.Methods A total of 80 patients with COPD who were admitted to the Department of Geriatrics of Taixing Hospital of Traditional Chinese Medicine from January 2020 to May 2022 and whose TCM syndrome differentiation results were phlegm turbidity obstructing lung type were selected as the research ob-jects.All patients were admitted to the hospital due to acute exacerbation of the disease.They were divided into two groups according to the random lottery method,with 40 cases in each group.The control group was treated with Western medicine,while the observation group was treated with Suzi Jiangqi decoction and Sanzi yangqin decoction.Both groups were treated for 2 weeks.The TCM syndrome score,pulmonary function index,effective rate of medication and incidence of adverse reactions were compared between the two groups.Results After 2 weeks of treatment,the TCM syndrome score of observation group was lower than that of control group,and the index of lung function in observation group was better than that in control group,and the differences were statis-tically significant(both P<0.05).The effective rate of the observation group was 97.50%,which was higher than that of the control group 82.50%,and the difference was statistically significant(χ2=5.000,P=0.025).The inci-dence of adverse reactions in the observation group was 5.00%compared with 10.00%in the control group,and the difference was not statistically significant(χ2=0.721,P=0.396).Conclusion Suzi Jiangqi Decoction com-bined with Sanzi Yangqin Decoction in the treatment of acute exacerbation of chronic obstructive pulmonary dis-ease with phlegm turbidity obstructing the lung type can improve traditional Chinese medicine syndrome and lung function of patients,and ensure the effect and safety of medication.

关键词

慢性阻塞性肺疾病/痰浊壅肺型/急性加重期/中医证候积分/肺功能

Key words

Chronic obstructive pulmonary/Phlegm turbidity obstructing lung type/Acute exacerbation stage/Traditional Chinese medicine syndrome score/Lung function

引用本文复制引用

基金项目

江苏省中医药局科技项目(YB2017086)

出版年

2024
世界复合医学

世界复合医学

ISSN:
段落导航相关论文